Dicyclomine Hydrochloride Tablet
Product Images NDC 51655-257

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dicyclomine Hydrochloride (NDC 51655-257). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 257 52 Master Bottle Label Approval Rev A 02 21)

Label (51655 257 52 Master Bottle Label Approval   Rev A 02 21)
NDC 51655-257-52 is a prescription drug containing 30 tablets of Dicyclomine HCI USP in each container, with each tablet having 20mg of the drug. The medication is produced by Actavis Pharma, Inc. and repackaged by Northwind Pharmaceuticals. The drug is meant to be stored at a temperature range of 20°C to 25°C and is to be kept away from children in its original container. The package insert should be consulted for proper dosage administration. The GTIN is 00351655257524 and S/N is 000000000000000. The expiration date is 00/00/0000. This medication is a generic version of Bentyl and is used to treat irritable bowel syndrome.*
FDA Label Image

Dicyclomine Hydrochloride Structural Formula (Image 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.